BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 28984674)

  • 21. Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (
    Kim H; Yoon N; Woo HY; Lee EJ; DO SI; Na K; Kim HS
    Cancer Genomics Proteomics; 2020; 17(6):813-826. PubMed ID: 33099482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.
    Ma T; Chai M; Shou H; Ru G; Zhao M
    Front Oncol; 2022; 12():911695. PubMed ID: 35865471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesonephric adenocarcinoma of the uterine corpus.
    Wu H; Zhang L; Cao W; Hu Y; Liu Y
    Int J Clin Exp Pathol; 2014; 7(10):7012-9. PubMed ID: 25400789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
    Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
    Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesonephric Adenocarcinoma of the Uterine Corpus: A Report on 2 Cases With Comparison to Its Cervical Counterpart.
    Liang Y; Shi H; Zhu X; Yu M; Zhang X
    Int J Gynecol Pathol; 2020 Nov; 39(6):546-551. PubMed ID: 31985582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases].
    Liang Y; Ruan HJ; Wang WS; Yu MH; Chen XD; Zhang XF
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):791-795. PubMed ID: 34405616
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian Components: A Case Report With Molecular Analysis Demonstrating Multidirectional Mullerian Differentiation.
    Stolnicu S; Bartalis RJ; Ye Q; Da Cruz Paula A; Weigelt B; Soslow RA
    Int J Gynecol Pathol; 2023 Nov; 42(6):620-626. PubMed ID: 36617679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas.
    Chapel DB; Joseph NM; Krausz T; Lastra RR
    Int J Gynecol Pathol; 2018 Sep; 37(5):448-459. PubMed ID: 28863071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas.
    Mirkovic J; Olkhov-Mitsel E; Amemiya Y; Al-Hussaini M; Nofech-Mozes S; Djordjevic B; Kupets R; Seth A; McCluggage WG
    Histopathology; 2023 Jun; 82(7):978-990. PubMed ID: 36860193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor.
    Wu RC; Chen SJ; Chen HC; Tan KT; Jung SM; Lin CY; Chao AS; Huang KG; Chou HH; Chang TC; Chao A; Lai CH
    Mod Pathol; 2020 Dec; 33(12):2534-2543. PubMed ID: 32616873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
    Choi KH; Kim H; Bae GE; Lee SH; Woo HY; Kim HS
    Anticancer Res; 2021 Sep; 41(9):4587-4601. PubMed ID: 34475087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior.
    McCluggage WG
    Adv Anat Pathol; 2022 Jul; 29(4):208-216. PubMed ID: 35384888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
    Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
    Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
    Jang S; Hong M; Shin MK; Kim BC; Shin HS; Yu E; Hong SM; Kim J; Chun SM; Kim TI; Choi KC; Ko YW; Kim JW
    Hum Pathol; 2017 Jul; 65():21-30. PubMed ID: 28188750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
    Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.
    Ritterhouse LL; Nowak JA; Strickland KC; Garcia EP; Jia Y; Lindeman NI; Macconaill LE; Konstantinopoulos PA; Matulonis UA; Liu J; Berkowitz RS; Nucci MR; Crum CP; Sholl LM; Howitt BE
    Mod Pathol; 2016 Aug; 29(8):893-903. PubMed ID: 27150160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
    Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.